At a glance
Curaleaf Holdings is a publicly traded cannabis company with vertically integrated operations in the United States and a separate international medical-cannabis business. Its lineage begins with PalliaTech, formed in New Jersey in 2010; the Curaleaf name arrived in 2018 before a public-company combination. Today the Curaleaf name covers both dispensaries and products, while Select, Grassroots, Find, JAMS and other labels serve distinct categories.
From PalliaTech to Curaleaf
Corporate filings state that Curaleaf Inc., formerly PalliaTech Inc., was formed in 2010 and began in New Jersey. PalliaTech changed its name to Curaleaf in August 2018, and an October 2018 business combination created the present public issuer. That sequence is more accurate than treating the 2018 rebrand as the company’s founding.
Leadership, investors and founders
Boris Jordan was an early investor, became executive chairman of PalliaTech in 2014, acquired majority control in 2015 and now serves as Curaleaf’s chairman and CEO. Joseph Lusardi led major operational growth from 2015 and is now executive vice chairman. The reviewed filings do not label either man as the sole original founder of the 2010 company, so this profile keeps control, leadership and founding distinct.
U.S. products and brands
Curaleaf’s 2025 filing lists flower, pre-rolls, vaporizer cartridges, concentrates, topicals, tinctures, edibles and beverages. Its domestic national brands include Curaleaf, Anthem, Find, Grassroots, JAMS, Reef and Select; Dark Heart also appears in the trademark portfolio. Products and formats vary by state, and Pennsylvania, for example, permits troches but prohibits ordinary edibles.
Acquisitions that changed the portfolio
Curaleaf’s current scale was built partly through acquisitions. In 2019 it acquired Select, a major vape and wholesale brand. The 2020 Grassroots acquisition expanded licenses and cultivation/retail operations, bringing co-founder and CEO Mitchell Kahn into the broader organization. Those brands remain distinct consumer labels even though Curaleaf owns them.
Dispensaries and U.S. footprint
As of December 31, 2025, Curaleaf reported 159 dispensaries across 14 U.S. states, along with 18 manufacturing sites and 15 cultivation sites. Florida accounted for 70 of those stores at that date. The company also disclosed an Oregon brand-licensing agreement outside the table. Store totals change frequently, so the dated filing is a baseline rather than a promise of the present-day count.
International operations
Curaleaf International operates medical-cannabis cultivation, manufacturing, wholesale, clinic or pharmacy activities across parts of Europe, Canada and Australasia. The prominent international brands named in the filing are Curaleaf, Four20 and Huala. Medical access, prescriptions, allowed formats and manufacturing standards differ by country and should not be inferred from a U.S. dispensary menu.
Research and public-company milestones
The company reports extensive research activity through Curaleaf International and launched numerous products and genetics in 2025. In September 2025, Curaleaf joined the S&P/TSX Composite Index, which it described as a first for a U.S.-based cannabis operator. Index inclusion is a capital-markets milestone, not a clinical endorsement or guarantee of investment performance.
March 2026 UK recall
On March 12, 2026, the UK Medicines and Healthcare products Regulatory Agency announced a Class 2 recall of three batches of Curaleaf Oil [FS] 10 mg/ml THC and 10 mg/ml CBD because stability testing found THC below the acceptable level. The recall applied at wholesaler and pharmacy level; the notice said no patient action was required and no adverse events had been received. It should not be generalized to unrelated Curaleaf products or U.S. dispensaries.
How to read the brand. Curaleaf is simultaneously a parent company, a retail banner and a product brand. A store can sell both Curaleaf-owned and third-party products, while a Select or Grassroots package may be manufactured by a state-specific Curaleaf subsidiary. The exact label, state license, batch test and local menu are the proper sources for a specific product.
Sources and verification scope. Checked August 23, 2026: Curaleaf’s 2025 annual information form and financial filing; the 2018 listing and business-combination disclosures; current brand materials; and the UK regulator’s March 2026 recall. Counts are dated, leadership roles are separated from founding, and the recall is described only at its documented batch and jurisdictional scope.